Medivir and Biossil Team Up to Develop New Cancer Treatment
Medivir AB has partnered with Biossil Inc. to develop remetinostat, a drug applied to the skin that is currently in […]
Simplifying Clinical Trials: Less Data Could Mean Better Results
In the world of drug development, collecting data is crucial. However, a recent study suggests that too much data can
Johnson & Johnson’s Big Changes: What It Means for Your Medicines
Johnson & Johnson (J&J) has been making significant changes in recent years. The company has been focusing more on pharmaceuticals
How Community Pharmacies Are Simplifying Complex Healthcare
Healthcare is becoming more complex, especially as people live longer and develop chronic conditions. New treatments, like cell and gene
News
Rentschler Biopharma Builds New Production Facility in Germany
Rentschler Biopharma is constructing a new production facility at its headquarters in Laupheim, Germany. This is the company’s biggest investment
New Study Shows Promise in Treating Menopause Symptoms
Astellas Pharma has shared promising early results from its ongoing OPTION-VMS study. The study, which includes over 900 women aged
Eli Lilly to Invest $1.3 Billion in New Drug Discovery
Eli Lilly, a major pharmaceutical company, has announced plans to invest up to $1.3 billion in Superluminal Medicines. This partnership
News
US to Stockpile Key Drug Ingredients to Strengthen Supply
President Trump has issued an order to boost the US supply of essential medicines. The plan focuses on stockpiling key
Eli Lilly Invests $1.3 Billion in AI-Powered Drug Discovery for Obesity and Metabolic Diseases
Eli Lilly, a major pharmaceutical company, is teaming up with Superluminal Medicines to develop new treatments for obesity and metabolic
Vertex Pharmaceuticals Announces Leadership Change as Key Scientist Retires
Vertex Pharmaceuticals, a leading biotech company, has announced that Dr. David Altshuler, its Chief Scientific Officer, will retire on August